Department of Pathology and Molecular Medicine, Queen's University, Kingston, ON, Canada.
Department of Medicine, Queen's University, Kingston, ON, Canada.
J Thromb Haemost. 2019 Apr;17(4):681-694. doi: 10.1111/jth.14404. Epub 2019 Mar 19.
Essentials CLEC4M is an endocytic receptor for factor FVIII. CLEC4M interacts with FVIII in a VWF-dependent and independent manner. CLEC4M binds to mannose-containing glycans on FVIII. CLEC4M internalization of FVIII involves clathrin coated pits. SUMMARY: Background von Willebrand factor (VWF) and factor VIII (FVIII) circulate in the plasma as a non-covalent complex, and the majority of FVIII is likely to be cleared by VWF-dependent pathways. Clearance of VWF-free FVIII is rapid and underlies the pathological basis of some quantitative FVIII deficiencies. The receptor pathways that regulate the clearance of VWF-bound and VWF-free FVIII are incompletely uncharacterized. The human liver-expressed endothelial lectin CLEC4M has been previously characterized as a clearance receptor for VWF, although its influence on FVIII is unknown. Objective The interaction between FVIII and CLEC4M was characterized in the presence or absence of VWF. Methods FVIII interactions with CLEC4M were evaluated by in vitro cell-based and solid phase binding assays. Interactions between FVIII and CLEC4M or liver sinusoidal endothelial cells were evaluated in vivo by immunohistochemistry. Results CLEC4M-expressing HEK 293 cells bound and internalized recombinant and plasma-derived FVIII through VWF-dependent and independent mechanisms. CLEC4M binding to recombinant FVIII was dependent on mannose-exposed N-linked glycans. CLEC4M mediated FVIII internalization via a clathrin-coated pit-dependent mechanism, resulting in transport of FVIII from early and late endosomes for catabolism by lysosomes. In vivo hepatic expression of CLEC4M after hydrodynamic liver transfer was associated with a decrease in plasma levels of endogenous murine FVIII:C in normal mice, whereas infused recombinant human FVIII was associated with sinusoidal endothelial cells in the presence or absence of VWF. Conclusions These findings suggest that CLEC4M is a novel clearance receptor that interacts with mannose-exposed glycans on FVIII in the presence or absence of VWF.
CLEC4M 是 FVIII 的内吞受体。CLEC4M 以 VWF 依赖和不依赖的方式与 FVIII 相互作用。CLEC4M 结合 FVIII 上含有甘露糖的糖基。CLEC4M 内化 FVIII 涉及网格蛋白包被的陷窝。
背景 血管性血友病因子 (VWF) 和因子 VIII (FVIII) 在血浆中作为非共价复合物循环,并且大多数 FVIII 可能通过 VWF 依赖途径清除。VWF 无 FVIII 的清除是快速的,这是一些定量 FVIII 缺乏症的病理基础。调节 VWF 结合和 VWF 无 FVIII 清除的受体途径尚未完全阐明。人类肝脏表达的内皮凝集素 CLEC4M 先前被表征为 VWF 的清除受体,尽管其对 FVIII 的影响尚不清楚。
目的 在存在或不存在 VWF 的情况下,研究 FVIII 与 CLEC4M 之间的相互作用。
方法 通过体外细胞结合和固相结合测定评估 FVIII 与 CLEC4M 的相互作用。通过免疫组织化学在体内评估 FVIII 与 CLEC4M 或肝窦内皮细胞之间的相互作用。
结果 表达 CLEC4M 的 HEK 293 细胞通过 VWF 依赖和不依赖的机制结合和内化重组和血浆衍生的 FVIII。CLEC4M 与重组 FVIII 的结合依赖于暴露于甘露糖的 N 连接糖基。CLEC4M 通过网格蛋白包被的陷窝依赖性机制介导 FVIII 内化,导致 FVIII 从早期和晚期内体运输到溶酶体进行代谢。在正常小鼠中,水力转移后肝脏表达 CLEC4M 与内源性小鼠 FVIII:C 血浆水平降低有关,而输注重组人 FVIII 与存在或不存在 VWF 的情况下均与窦内皮细胞有关。
结论 这些发现表明,CLEC4M 是一种新型清除受体,可与 VWF 存在或不存在时 FVIII 上暴露的甘露糖糖基相互作用。